Medical/Pharmaceuticals
NOVALIQ PRESENTS DATA FROM SECOND PHASE 3 TRIAL OF INVESTIGATIONAL TREATMENT CYCLASOL® (0.1% CYCLOSPORINE OPHTHALMIC SOLUTION) AT THE AMERICAN SOCIETY OF CATARACT AND REFRACTIVE SURGERY ANNUAL MEETING
HEIDELBERG, Germany, and CAMBRIDGE, Mass., April 26, 2022 /PRNewswire/ -- Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on the unique EyeSol® water-free technology, today announced that data from the second pivotal Phase 3 trial (ESSENCE-2) e...
2022-04-26 20:00
1254
SOPHiA GENETICS Hits Milestone of One Million Genomic Profiles Analyzed by the SOPHiA DDM™ Platform
BOSTON and LAUSANNE, Switzerland, April 26, 2022 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a leader in data-driven medicine, has reached the milestone of one million genomic profiles analyzed by its SOPHiA DDM™ Platform, securing its position as one of the largest knowledge sharing platform...
2022-04-26 19:57
1715
Holmusk Announces Publication of Seminal Paper on Real-World Evidence (RWE) Platform NeuroBlu
NEW YORK, April 26, 2022 /PRNewswire/ -- Holmusk, a leading global data science and health technology company building the world's largest real-world evidence (RWE) platform for behavioral health, is pleased to share with the scientific community in-depth details about its platform via thepublica...
2022-04-26 19:30
1688
Two Outstanding Hong Kong Startups Named Top Winners of Alibaba Entrepreneurs Fund/HSBC JUMPSTARTER 2022
Securing Investment Opportunity of Up to USD4 Million Healthcare and Sustainability become popular sectors among startups HONG KONG, April 26, 2022 /PRNewswire/ -- Alibaba Entrepreneurs Fund/HSBC JUMPSTARTER 2022 Global Pitch Competition ("JUMPSTARTER 2022") has concluded its Grand Finale. After...
2022-04-26 17:12
2757
SonoScape S-Fetus 4.0 Release to Simplify Sonography Process
SHENZHEN, China, April 26, 2022 /PRNewswire/ -- SonoScape Medical Corp. today announced the release of S-Fetus 4.0, the latest software upgrade of the company's flagship ultrasound product offering. This technical breakthrough marks S-Fetus 4.0 as the globally first smart obstetric screening tech...
2022-04-26 17:06
2091
Octapharma to address unmet needs in von Willebrand disease as a proud sponsor of WFH 2022 World Congress
LACHEN, Switzerland, April 26, 2022 /PRNewswire/ -- As part of its ongoing commitment to the global bleeding disorders community, Octapharma is pleased to be a Gold Sponsor of the upcoming World Federation of Haemophilia (WFH) 2022 World Congress, taking place fromMay 8 to 11, 2022. This continue...
2022-04-26 16:00
1721
The First International COVID-19 Testing Standard Released
BEIJING, April 26, 2022 /PRNewswire/ -- According to the State Administration for Market Regulation, the International Organization for Standardization (ISO) released the first international standard specifically for the detection of SARS-CoV-2, the virus that causes COVID-19. On April 19, ISO i...
2022-04-26 13:02
1254
Asia Pacific Initiative on Reproduction (ASPIRE) 2022 Congress: Tracking hormonal pathways linking stress with reproductive dysfunction and failure
SINGAPORE, April 26, 2022 /PRNewswire/ -- Advanced insights into the potential impacts of stress on human reproductive health will be reported at the 2022 Congress of the Asia Pacific Initiative on Reproduction (ASPIRE) starting on Thursday. The Congress will hear of profound interaction betw...
2022-04-26 12:20
1789
Adge Pharmaceuticals partners with Cyan Bio of Korea to advance treatments for rare pediatric diseases in Asian countries
MOUNTAIN VIEW, Calif., April 26, 2022 /PRNewswire/ -- Adge Pharmaceuticals ("Adge") has entered into a license agreement with Korea-based Cyan Bio, Inc. ("Cyan"). Cyan will receive exclusive rights for commercialization of elocalcitol in key territories inAsia for the treatment of the Rett Syndro...
2022-04-26 07:00
1338
SOFWAVE™ Is This Year's NewBeauty Award Winner!
"Best Latest in Ultrasound" SAN CLEMENTE, Calif., April 25, 2022 /PRNewswire/ -- Sofwave Medical Ltd (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, proudly announces that Sofwave™, the latest game-changing ultrasound technolo...
2022-04-25 20:00
1839
JW Therapeutics Announces its Cell Immunotherapy Drugs Have Successfully Benefited 200 Chinese Patients
SHANGHAI, April 25, 2022 /PRNewswire/ -- JW Therapeutics (HKEx: 2126), an independent and innovative biotechnology company focused on developing, manufacturing and commercializing cell immunotherapy products, disclosed that as ofApril 12, 2022, its cell immunotherapy drugs have been successfully ...
2022-04-25 15:08
2519
Extract Technology announces ISO 9001 Manufacturing Expansion in the UK
LONDON, April 25, 2022 /PRNewswire/ -- Extract Technology and the Dec Group (Dietrich Engineering Consultants) announce a significant expansion of their UK ISO 9001 manufacturing facility located inHuddersfield, UK. The Bradley Junction site expansion includes the acquisition of an additional bui...
2022-04-25 15:00
1532
Bee and Honey Promote Medical and Healthcare Products via Virtual Event
GUANGZHOU, China, April 25, 2022 /PRNewswire/ -- On 16 April, with the theme of "Fight against Pandemic, Care for Each Other", the second trade promotion activity of "Discover Canton Fair with Bee and Honey" was successfully held on Canton Fair's official Facebook account. The virtual event was h...
2022-04-25 11:28
1655
CanSinoBIO Rebrands to Reflect Commitment to Life Sciences Research
TIANJIN, China, April 25, 2022 /PRNewswire/ -- CanSino Biologics Inc. ("CanSinoBIO" of "the Company") (SSE: , HKEX: 06185) today announced its new brand identity, which is intended to represent the Company's continuous dedication to life sciences research and its commitment to protecting the glo...
2022-04-25 08:00
2340
Novo Nordisk Indonesia takes a holistic approach to achieve zero environmental impact
JAKARTA, Indonesia, April 22, 2022 /PRNewswire/ -- In an attempt to achieve the company's ultimate goal to have zero environmental impact, Novo Nordisk Indonesia has initiated various activities, including switching the company's delivery method from air freight to sea freight and launching an in...
2022-04-22 17:39
3275
CStone Announces Results From Phase 3 AGILE Data of TIBSOVO® (ivosidenib tablets) in Combination with Azacitidine for Patients with Previously Untreated IDH1-mutated Acute Myeloid Leukemia Published in the New England Journal of Medicine
* Results from the trial present a significant advancement for patients dealing with previously untreated IDH1-mutated AML * Global Phase 3 trial of TIBSOVO (ivosidenib tablets) met its primary endpoint of event-free survival and all key secondary endpoints, complete remission rate, overall s...
2022-04-22 08:02
3129
Lynk Pharmaceuticals Announces Clinical Approval in China for Its Class I New Drug LNK01004
HANGZHOU, China, April 22, 2022 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as 'Lynk Pharmaceuticals'), an innovative clinical stage company, announced that its Class I innovative drug LNK01004, has been approved by National Medical Products Administration (NMPA) for c...
2022-04-22 08:00
2816
Telix Further Strengthens European Distribution Network for Illuccix
MELBOURNE, Australia and LIÈGE, Belgium, April 22, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces agreements with Sociedade Avanço, Unipessoal, LDA (Avanço) and THP Medical Products Vertriebs GmbH (THP) for the distribution of Telix's prostate ca...
2022-04-22 07:10
2826
Terran Biosciences announces licensing deal with Sanofi for two late-stage CNS pipeline assets
* Terran to advance the development of two of Sanofi's Phase 3 CNS therapeutics * Transaction includes worldwide exclusive rights for development and commercialization in all fields of use NEW YORK, April 21, 2022 /PRNewswire/ -- Terran Biosciences, Inc. ("Terran"), a biotech platform company...
2022-04-21 22:39
3171
Transcenta Successfully Passed the Audit of EU Qualified Person for the Manufacturing of TST001
SUZHOU, China, April 21, 2022 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces that HJB (Hangzhou) ...
2022-04-21 19:20
2458
Week's Top Stories
Most Reposted
k-ID Closes $45 Million Series A from Andreessen Horowitz and Lightspeed Venture Partners to Set a New Global Benchmark for Age-appropriate Gaming Experiences
[Picked up by 320 media titles]
2024-06-25 21:00
10 Start-ups Awarded in HK Tech 300 Southeast Asia Start-up Competition Fostering Innovation & Entrepreneurship Beyond Boundaries
[Picked up by 317 media titles]
2024-06-27 18:56
Labuan IBFC Inc. and STEP Malaysia jointly host wealth management and estate planning event
[Picked up by 315 media titles]
2024-06-28 12:45
SCO strengthening youth development for better future
[Picked up by 297 media titles]
2024-06-24 10:52
Fibocom Drives the Rapid Growth in the Economics of IoT Scale with Ultra-compact size Cat 1 bis Module MC610-GL at MWC Shanghai 2024
[Picked up by 286 media titles]
2024-06-26 10:00
Most Read
k-ID Closes $45 Million Series A from Andreessen Horowitz and Lightspeed Venture Partners to Set a New Global Benchmark for Age-appropriate Gaming Experiences
2024-06-25 21:00
12815
Lilyannie Christie Linus Crowned Miss Grand Malaysia Sabah 2024
2024-06-25 13:38
12436
SCO strengthening youth development for better future
2024-06-24 10:52
7191